Erythropoietin abuse and erythropoietin gene doping: Detection strategies in the genomic era

Sports Medicine

Volumn 35, Issue 10, 2005, Pages 831-840

  Diamanti Kandarakis, Evanthia ^a,d   Konstantinopoulos, Panagiotis A ^b   Papailiou, Joanna ^a   Kandarakis, Stylianos A ^a   Andreopoulos, Anastasios ^a   Sykiotis, Gerasimos P ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMATIDE; LIPOSOME; MIFEPRISTONE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXYGEN DERIVATIVE; PLASMID DNA; PROTEIN DERIVATIVE; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN; REPOXYGEN; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; ATHLETE; CELL ENCAPSULATION; CLINICAL TRIAL; DNA MICROARRAY; DOPING; DRUG ABUSE; DRUG DELIVERY SYSTEM; DRUG MISUSE; ENDURANCE; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GENETIC PROCEDURES; GENOMICS; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNITY; NONHUMAN; OXYGEN CONSUMPTION; PHYSICAL CHEMISTRY; SCREENING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

DOPING IN SPORTS; ERYTHROPOIETIN; GENOMICS; HUMANS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 26844515726     PISSN: 01121642     EISSN: 01121642     Source Type: Journal    
DOI: 10.2165/00007256-200535100-00001     Document Type: Article

References (46)

1. Loeb Classical Library. Homer the Iliad (translated by Murray AT). Cambridge (MA): Harvard University Press, 1925: 551-3
2. Noakes TD. Tainted glory: doping and athletic performance. N Engl J Med 2004 Aug 26; 351 (9): 847-9
3. Fisher JW. Erythropoietin: physiology and pharmacology upate. Exp Biol Med (Maywood) 2003 Jan; 228 (1): 1-14
4. Lacombe C, Mayeux P. The molecular biology of erythropoie tin. Nephrol Dial Transplant 1999; 14 Suppl. 2: 22-8
5. Chong ZZ, Kang JQ, Maiese K. Angiogenesis and plasticity: role of erythropoietin in vascular systems. J Hematother Stem Cell Res 2002 Dec; 11 (6): 863-71
6. Gaudard A, Varlet-Marie E, Bressolle F, et al. Drugs for in creasing oxygen and their potential use in doping: a review. Sports Med 2003; 33 (3): 187-212
7. Eagleton HJ, Littlewood TJ. Update on the clinical use and misuse of erythropoietin. Curr Haematol Rep 2003 Mar; 2 (2):109-15
8. Fukuda MN, Sasaki H, Lopez L, et al. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood 1989 Jan; 73 (1): 84-9
9. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 2001; 16 Suppl. 3: 3-13
10. Lasne F, de Ceaurriz J. Recombinant erythropoietin in urine. Nature 2000 Jun 8; 405 (6787): 635
11. Aventis Pharma. Dynepo product update: Dynepo™ (epoietin delta) Gene Activated® Erythropoietin [online]. Available from URL: http://www.tktx.com/legal/PDFs/ Product_update.pdf [Accessed 2004 Aug 10]
12. Wilber RL. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid. Sports Med 2002; 32 (2):125-42
13. Parisotto R, Wu M, Ashenden MJ, et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 2001 Feb; 86 (2):128-37
14. Sharpe K, Hopkins W, Emslie KR, et al. Development of reference ranges in elite athletes for markers of altered erythropoiesis. Haematologica 2002 Dec; 87 (12): 1248-57
15. Gore CJ, Parisotto R, Ashenden MJ, et al. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 2003 Mar; 88 (3): 333-44
16. Parisotto R, Ashenden MJ, Gore CJ, et al. The effect of common haematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes. Haematologica 2003 Aug; 88 (8): 931-40
17. Lasne F, Martin L, Crepin N. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem 2002 Dec 15; 311 (2): 119-26
18. Kochendoerfer GG, Chen SY, Mao F, et al. Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Science 2003 Feb 7; 299 (5608): 884-7
19. Wells JA. Hormone mimicry. Science 1996 Jul 26; 273 (5274):449-50
20. Tilbrook PA, Klinken SP. The erythropoietin receptor. Int J Biochem Cell Biol 1999 Oct; 31 (10): 1001-5
21. Tilbrook PA, Klinken SP. Erythropoietin and erythropoietin receptor. Growth Factors 1999; 17 (1): 25-35
22. Barbone FP, Johnson DL, Farrell FX, et al. New epoetin molecules and novel therapeutic approaches. Nephrol Dial Trans-plant 1999; 14 Suppl. 2: 80-4
23. Qureshi SA, Kim RM, Konteatis Z, et al. Mimicry of erythropoietin by a nonpeptide molecule. Proc Natl Acad Sci U S A 1999 Oct 12; 96 (21): 12156-61
24. Pascual JA, Belalcazar V, de Bolos C, et al. Recombinant erythropoietin and analogues: a challenge for doping control. Ther Drug Monit 2004 Apr; 26 (2): 175-9
25. Woodburn KW, Fan Q, Leuther KK, et al. Preclinical evaluation of Hematide™, a novel erythropoietic receptor agonist for the treatment of anemia caused by kidney disease [abstract no. 2904]. 46th Annual American Society of Hematology Meeting; 2004 Dec 4-7; San Deigo (CA)
26. Yi T, Zhang J, Miura O, et al. Haematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Blood 1995 Jan 1; 85 (1): 87-95
27. Dalle B, Payen E, Regulier E, et al. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts. Gene Ther 1999 Feb; 6 (2): 157-61
28. Regulier E, Schneider BL, Deglon N, et al. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts. Gene Ther 1998 Aug; 5 (8): 1014-22
29. Rinsch C, Dupraz P, Schneider BL, et al. Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia. Kidney Int 2002 Oct; 62 (4): 1395-401
30. Unal M, Ozer Unal D. Gene doping in sports. Sports Med 2004; 34 (6): 357-62
31. Svensson EC, Black HB, Dugger DL, et al. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 1997 Oct 10; 8 (15): 1797-806
32. Danko I, Williams P, Herweijer H, et al. High expression of naked plasmid DNA in muscles of young rodents. Hum Mol Genet 1997 Sep; 6 (9): 1435-43
33. Johnston J, Tazelaar J, Rivera VM, et al. Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model. Mol Ther 2003 Apr; 7 (4): 493-7
34. Abruzzese RV, Godin D, Mehta V, et al. Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system. Mol Ther 2000 Sep; 2 (3): 276-87
35. Ye X, Rivera VM, Zoltick P, et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 1999 Jan 1; 283 (5398): 88-91
36. Oxford Bio Medica. Successful preclinical results for new anaemia product [online]. Available from URL: http://www.oxfordbiomedica.co.uk/news/2002-ob-05. htm [Accessed 2004 Aug 10]
37. Adam D. Gene therapy may be up to speed for cheats at 2008 Olympics. Nature 2001 Dec 6; 414 (6864): 569-70
38. McCrory P. Super athletes or gene cheats? Br J Sports Med 2003 Jun; 37 (3): 192-3
39. Lasne F, Martin L, de Ceaurriz J, et al. 'Genetic doping' with erythropoietin cDNA in primate muscle is detectable. Mol Ther 2004 Sep; 10 (3): 409-10
40. Ooi SL, Shoemaker DD, Boeke JD. A DNA microarray-based genetic screen for nonhomologous end-joining mutants in Saccharomyces cerevisiae. Science 2001 Dec 21; 294 (5551): 2552-6
41. Malcovati L, Pascutto C, Cazzola M. Haematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 2003 May; 88 (5): 570-81
42. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000 Aug 17; 406 (6797): 747-52
43. Kolbus A, Blazquez-Domingo M, Carotta S, et al. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood 2003 Nov 1; 102 (9):3136-46
44. Gubin AN, Njoroge JM, Bouffard GG, et al. Gene expression in proliferating human erythroid cells. Genomics 1999 Jul 15; 59 (2): 168-77
45. DePrimo SE, Wong LM, Khatry DB, et al. Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification. BMC Cancer 2003 Feb 7; 3 (1): 3
46. Twine NC, Stover JA, Marshall B, et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 2003 Sep 15; 63 (18): 6069-75